Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1975-11-07
1980-07-08
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424182, 424361, A61K 3170, A61K 31705
Patent
active
042117704
ABSTRACT:
Pharmaceutical composition for treatment of proliferating skin diseases, primarily psoriasis. The compositions comprise a pharmaceutical carrier with a compound of the formula ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and selected from the group consisting of benzoyl, adamantane carboxylate or an acyl radical of an aliphatic carboxylic acid having from 2 to 18 carbon atoms inclusive including the pharmacologically acceptable acid addition salts thereof as the active compound.
The compositions are administered to humans and animals systemically or topically.
REFERENCES:
patent: 3849553 (1974-11-01), Dea et al.
Lapinet et al., Chem. Abst., vol. 80 (1974), p. 112,625r.
Fagelson Anna P.
Killinger John J.
The Upjohn Company
LandOfFree
Treatment of psoriasis intralesionally with N.sup.6 -2'-O-dibuty does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of psoriasis intralesionally with N.sup.6 -2'-O-dibuty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of psoriasis intralesionally with N.sup.6 -2'-O-dibuty will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-560499